HBV and hepatitis C virus (HCV) upregulate expression of serine protease inhibitor Kazal (SPIK), and SPINK1 is overexpressed in HCV-positive hepatocellular carcinoma (HCC) and thus is a promising prognostic marker for this cancer [8–10]. This evidence concerns the gene SPINK1 and hepatocellular carcinoma.